sitagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, type 2 - narkotika anvendt i diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. - , trepersoners-kombinationsbehandling) som supplement til diæt og motion hos patienter, der ikke er tilstrækkeligt kontrolleret på deres maksimal tolereret dosis af metformin og et sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
sitagliptin / metformin hydrochloride sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, type 2 - narkotika anvendt i diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. - , trepersoners-kombinationsbehandling) som supplement til diæt og motion hos patienter, der ikke er tilstrækkeligt kontrolleret på deres maksimal tolereret dosis af metformin og et sulphonylurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
levetiracetam "aristo" 100 mg/ml oral opløsning
aristo pharma gmbh - levetiracetam - oral opløsning - 100 mg/ml
cidofovir "macure" 75 mg/ml koncentrat til infusionsvæske, opløsning
macure pharma aps - cidofovirdihydrat - koncentrat til infusionsvæske, opløsning - 75 mg/ml
iasibon
pharmathen s.a. - ibandronsyre - hypercalcemia; fractures, bone; neoplasm metastasis; breast neoplasms - narkotika til behandling af knoglesygdomme - concentrate for solution for infusion prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases. behandling af tumor-induceret hypercalcaemia med eller uden metastaser. film-coated tablets prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.
arzotilol 20+5 mg/ml øjendråber, opløsning
actavis group ptc ehf. - dorzolamidhydrochlorid, timololmaleat - øjendråber, opløsning - 20+5 mg/ml
bendamustin "actavis" 2,5 mg/ml pulver til koncentrat til infusionsvæske, opløsning
actavis group ptc ehf. - bendamustinhydrochlorid - pulver til koncentrat til infusionsvæske, opløsning - 2,5 mg/ml
bimatoprost/timolol "stada" 0,3+5 mg/ml øjendråber, opløsning
stada arzneimittel ag - bimatoprost, timololmaleat - øjendråber, opløsning - 0,3+5 mg/ml
gemcitabin "fresenius kabi" 38 mg/ml pulver til infusionsvæske, opløsning
fresenius kabi ab - gemcitabinhydrochlorid - pulver til infusionsvæske, opløsning - 38 mg/ml
fulvestrant "medical valley" 250 mg injektionsvæske, opløsning i fyldt injektionssprøjte
medical valley invest ab - fulvestrant - injektionsvæske, opløsning i fyldt injektionssprøjte - 250 mg